MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


Creightons continues to have 'serious' interest in merger offer for Innovaderma

StockMarketWire.com

Personal care and beauty company Creightons said its merger offer for Innovaderma was rejected, but stressed that it continued to have a "serious" interest in a combination of the two companies.

In letter sent to Innovaderma, Creightons said: 'The company's current thinking is that a ratio of 2 Creightons ordinary shares for every 3 Innovaderma ordinary shares would be an appropriate basis.

Based upon the mid-market price per Creightons ordinary share as at the close of business on 1 February 2021 of 66 pence, this offer represented a value of 44p per Innovaderma ordinary share and a premium of 3.5% over the mid-market price per Innovaderma ordinary share of 42.5p at the close of business on 1 February 2021.

The company made a preliminary approach on 26 January 2021 to Innovaderma regarding a possible offer, but this approach was unequivocally rejected by the latter's board on 29 January 2021 without 'affording Creightons the benefit of any further discussion,' the company said.

Under market rules Creightons WAS required, by no later than 5.00 pm (London time) on 2 March, 2021, to announce a firm intention to make an offer for Innovaderma or walk away.

At 9:46am: (LON:CRL) Creightons PLC share price was 0p at 50p


Story provided by StockMarketWire.com